X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
chemotherapy (6) 6
humans (6) 6
index medicus (6) 6
medicine, general & internal (6) 6
abridged index medicus (5) 5
adult (5) 5
female (5) 5
middle aged (5) 5
aged (4) 4
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
clinical trials (4) 4
randomized-trial (4) 4
survival analysis (4) 4
chemotherapy, adjuvant (3) 3
male (3) 3
aged, 80 and over (2) 2
anthracyclines - administration & dosage (2) 2
brain neoplasms - drug therapy (2) 2
brain neoplasms - radiotherapy (2) 2
breast neoplasms - drug therapy (2) 2
breast neoplasms - genetics (2) 2
cancer (2) 2
carcinoma, non-small-cell lung - drug therapy (2) 2
carcinoma, non-small-cell lung - mortality (2) 2
care and treatment (2) 2
cisplatin - administration & dosage (2) 2
diagnosis (2) 2
epirubicin - administration & dosage (2) 2
fluorouracil (2) 2
gene amplification (2) 2
genes, erbb-2 (2) 2
growth-factor receptor (2) 2
lung cancer (2) 2
lung cancer, non-small cell (2) 2
lung neoplasms - drug therapy (2) 2
lung neoplasms - mortality (2) 2
malignant glioma (2) 2
oncology (2) 2
premenopause (2) 2
prognosis (2) 2
radiation-therapy (2) 2
radiotherapy (2) 2
receptor, erbb-2 - genetics (2) 2
receptor, erbb-2 - metabolism (2) 2
survival (2) 2
temozolomide (2) 2
therapy (2) 2
usage (2) 2
5-fluorouracil (1) 1
adjuvant chemotherapy (1) 1
adjuvant treatment (1) 1
adrenal cortex hormones - therapeutic use (1) 1
adrenal cortex hormones/therapeutic use adult aged antineoplastic agents, alkylating/adverse effects/therapeutic use brain neoplasms/drug therapy/mortality/radiotherapy chemotherapy, adjuvant dacarbazine/adverse effects/analogs & derivatives/therapeutic use disease progression female glioblastoma/drug therapy/mortality/radiotherapy humans male middle aged proportional hazards models radiotherapy, computer-assisted/adverse effects survival analysis (1) 1
advanced colorectal-cancer (1) 1
age factors (1) 1
antineoplastic agents - administration & dosage (1) 1
antineoplastic agents, alkylating - adverse effects (1) 1
antineoplastic agents, alkylating - therapeutic use (1) 1
antineoplastic combined chemotherapy protocols (1) 1
antineoplastic combined chemotherapy protocols - administration & dosage (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
biomarkers, tumor - genetics (1) 1
biomarkers, tumor - metabolism (1) 1
bladder cancer (1) 1
brain cancer (1) 1
brain neoplasms - genetics (1) 1
brain neoplasms - mortality (1) 1
brain-tumor-group (1) 1
breast cancer (1) 1
breast neoplasms - metabolism (1) 1
breast neoplasms - mortality (1) 1
cancer therapies (1) 1
carcinoma, non-small-cell lung - surgery (1) 1
carmustine (1) 1
chemotherapy regimens (1) 1
cisplatin (1) 1
cisplatin - adverse effects (1) 1
cmv (1) 1
cyclophosphamide (1) 1
cyclophosphamide - administration & dosage (1) 1
dacarbazine - adverse effects (1) 1
dacarbazine - analogs & derivatives (1) 1
dacarbazine - therapeutic use (1) 1
disease progression (1) 1
disease-free survival (1) 1
docetaxel (1) 1
dosage and administration (1) 1
double-blind method (1) 1
doxorubicin (1) 1
drug therapy (1) 1
erlotinib hydrochloride (1) 1
fluorouracil - administration & dosage (1) 1
follow-up (1) 1
follow-up studies (1) 1
gefitinib (1) 1
gene expression regulation, neoplastic (1) 1
glioblastoma - drug therapy (1) 1
glioblastoma - mortality (1) 1
glioblastoma - radiotherapy (1) 1
glioblastoma multiforme (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 06/2005, Volume 352, Issue 25, pp. 2589 - 2597
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2005, Volume 353, Issue 2, pp. 123 - 132
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2006, Volume 354, Issue 20, pp. 2103 - 2111
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2005, Volume 352, Issue 10, pp. 987 - 996
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 04/1999, Volume 17, Issue 4, pp. 1194 - 1199
Purpose: To evaluate the efficacy and safety of the multitargeted antifolate LY231514 (MTA) in patients receiving initial chemotherapy for unresectable,... 
THYMIDYLATE SYNTHASE INHIBITORS | 5-FLUOROURACIL | THERAPY | ONCOLOGY | FLUOROURACIL | ADVANCED COLORECTAL-CANCER
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2006, Volume 355, Issue 8, pp. 845 - 846
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.